Head & Neck Cancers | Specialty

The OncLive Head and Neck Cancer condition center page is a comprehensive resource for clinical news and expert insights on treatment for patients with head and neck cancer. This page features news articles, interviews in written and video format, and podcasts that focus on unmet needs, treatment advances, and ongoing research within head and neck cancer.

A Strategy Built on Shared Values May Help Boost HPV Vaccination Rate

December 4th 2018

Maurie Markman, MD, discusses the steps that the scientific community needs to take to increase public acceptance of the vaccine against the human papillomavirus.

Dr. Drilon Discusses the FDA Approval of Larotrectinib

November 27th 2018

Alexander Drilon, MD, medical oncologist, clinical director, Early Drug Development Service, Memorial Sloan Kettering Cancer Center, discusses the FDA approval larotrectinib in NTRK-positive cancers.

Burtness Breaks Down Pembrolizumab Data in HNSCC

November 26th 2018

Barbara A. Burtness, MD, discusses the impact that the KEYNOTE-048 data could have on the treatment of patients with head and neck squamous cell carcinoma.

The HPV Puzzle: Quest to Deintensify Therapy in Oropharyngeal Cancer Continues

November 6th 2018

After more than 2 decades of change in the epidemiology of oropharyngeal cancers, the choice of optimal treatment for patients with human papillomavirus–positive disease remains elusive.

Dr. Burtness on Frontline Immunotherapy in Head and Neck Cancer

November 1st 2018

Barbara Burtness, MD, professor of medicine, Yale Cancer Center, discusses frontline immunotherapy in head and neck cancer.

Advice for Managing Patients With Thyroid Cancer

October 26th 2018

Emerging Therapies in Differentiated Thyroid Cancer

October 26th 2018

Precision Medicine in Differentiated Thyroid Cancer

October 26th 2018

Differentiated Thyroid Cancer: Sequencing of MTK Inhibitors

October 26th 2018

RAI-Refractory Differentiated Thyroid Cancer: Lenvatinib

October 26th 2018

Practical Considerations for Treating With Sorafenib

October 26th 2018

RAI-Refractory Differentiated Thyroid Cancer: Sorafenib

October 26th 2018

The RIFTOS MKI Study in Differentiated Thyroid Cancer

October 26th 2018

Systemic Therapy for Differentiated Thyroid Cancer

October 26th 2018

Differentiated Thyroid Cancer: RAI Failure and Survival

October 26th 2018

Differentiated Thyroid Cancer: Risk Stratification

October 26th 2018

Approaching RAI-Refractory Differentiated Thyroid Cancer

October 26th 2018

Radioactive Iodine for Differentiated Thyroid Cancer

October 26th 2018

Surgery for Differentiated Thyroid Cancer

October 26th 2018

Expert Management of Differentiated Thyroid Cancer

October 26th 2018